Qi He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qi He has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Chaoqun Han
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
4 shared publications - Jun Liu
Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4 shared publications - Yu Jin
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4 shared publications - Keyi Zhang
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province
3 shared publications - Rong Lin
Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publications - Guochen Shang
Division of Gastroenterology, The First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang Uygur Autonomous Region
2 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
Distributed Sample Allocation for the Diagnosis of Mass Lesions by EUS-FNA
Background: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)is a well-established, minimally invasive, interventional diagnostic endoscopic technique for the identification of mass lesions; however, its diagnostic accuracy needs further improvement. Most previous studies have focused on the choice of puncture techniques, and rare studies have investigated the effect of distributed sample allocation on the diagnostic accuracy of EUS-FNA. In this study, we aim to investigate the effect of distributed versus nondistributed sample allocation on EUS-FNA diagnostic accuracy. Methods: A total of 248 patients with mass lesions indicated by previous imaging examination were enrolled in this study. The patients were randomly assigned to 2 groups: distributed and nondistributed sample allocation. Clinicopathological features were collected retrospectively and analyzed. Results: Distributed sample allocation can raise the overall EUS-FNA diagnostic accuracy from 88.31% (nondistributed preservation) to 96.34% (distributed preservation). Distributed sample allocation was effective to further increase EUS-FNA diagnostic accuracy ( P =0.0262). Furthermore, for lesions of different locations, the diagnostic accuracy of EUS-FNA of lesions in the mediastinum and lung has improved ( P =0.0128). For lesions of different echogenicity, distributed allocation has effectively improved the diagnostic rate in cystic solid lesions ( P =0.0235). Conclusion: As a rarely considered approach, distributed sample allocation can improve the overall diagnostic accuracy of EUS-FNA.
- 26 October 2026
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
Open AccessDistributed Sample Allocation for the Diagnosis of Mass Lesions by EUS-FNA
Background: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)is a well-established, minimally invasive, interventional diagnostic endoscopic technique for the identification of mass lesions; however, its diagnostic accuracy needs further improvement. Most previous studies have focused on the choice of puncture techniques, and rare studies have investigated the effect of distributed sample allocation on the diagnostic accuracy of EUS-FNA. In this study, we aim to investigate the effect of distributed versus nondistributed sample allocation on EUS-FNA diagnostic accuracy. Methods: A total of 248 patients with mass lesions indicated by previous imaging examination were enrolled in this study. The patients were randomly assigned to 2 groups: distributed and nondistributed sample allocation. Clinicopathological features were collected retrospectively and analyzed. Results: Distributed sample allocation can raise the overall EUS-FNA diagnostic accuracy from 88.31% (nondistributed preservation) to 96.34% (distributed preservation). Distributed sample allocation was effective to further increase EUS-FNA diagnostic accuracy ( P =0.0262). Furthermore, for lesions of different locations, the diagnostic accuracy of EUS-FNA of lesions in the mediastinum and lung has improved ( P =0.0128). For lesions of different echogenicity, distributed allocation has effectively improved the diagnostic rate in cystic solid lesions ( P =0.0235). Conclusion: As a rarely considered approach, distributed sample allocation can improve the overall diagnostic accuracy of EUS-FNA.
- Open Access
- 26 September 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (19) , 2470
Diagnostic Value of EUS-FNA in the Differential Diagnosis of Esophageal Strictures Lacking Typical Malignant Features
Background: Esophageal strictures lacking typical malignant endoscopic features present a significant diagnostic challenge, often mimicking malignancy on imaging while concealing their true nature under regular white-light endoscopy. This study evaluated the utility of EUS-FNA in the differential diagnosis of such indeterminate strictures. Methods: We retrospectively analyzed 38 patients with suspicious malignant esophageal strictures indicated by CT but lacking definite malignant features on initial white-light gastroscopy. All patients underwent EUS-FNA for definitive pathological diagnosis. Clinicopathological data, imaging reports, endoscopic mucosal features, and procedural outcomes were assessed. Results: Among all 38 patients suspected of esophageal cancer by CT scan, 30 of them had malignant cytology results, including ESCC, EAC, metastatic cancer, and esophageal lymphoma. A total of 8 patients had benign findings, including esophageal tuberculosis, fungal esophagitis, eosinophilic esophagitis, and esophageal varices. Critically, EUS-FNA identified benign entities, such as eosinophilic esophagitis and esophageal tuberculosis masquerading as malignancy. CT features and mucosal features are also summarized and analyzed. Conclusions: EUS-FNA is a powerful tool for diagnosing esophageal strictures lacking typical malignant features. It reliably differentiates malignancy from challenging benign mimics, preventing misdiagnosis and guiding appropriate therapy. Clinicians should maintain a high suspicion for both occult malignancy and rare benign conditions in such stenotic lesions.
- 26 September 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (19) , 2470
Open AccessDiagnostic Value of EUS-FNA in the Differential Diagnosis of Esophageal Strictures Lacking Typical Malignant Features
Background: Esophageal strictures lacking typical malignant endoscopic features present a significant diagnostic challenge, often mimicking malignancy on imaging while concealing their true nature under regular white-light endoscopy. This study evaluated the utility of EUS-FNA in the differential diagnosis of such indeterminate strictures. Methods: We retrospectively analyzed 38 patients with suspicious malignant esophageal strictures indicated by CT but lacking definite malignant features on initial white-light gastroscopy. All patients underwent EUS-FNA for definitive pathological diagnosis. Clinicopathological data, imaging reports, endoscopic mucosal features, and procedural outcomes were assessed. Results: Among all 38 patients suspected of esophageal cancer by CT scan, 30 of them had malignant cytology results, including ESCC, EAC, metastatic cancer, and esophageal lymphoma. A total of 8 patients had benign findings, including esophageal tuberculosis, fungal esophagitis, eosinophilic esophagitis, and esophageal varices. Critically, EUS-FNA identified benign entities, such as eosinophilic esophagitis and esophageal tuberculosis masquerading as malignancy. CT features and mucosal features are also summarized and analyzed. Conclusions: EUS-FNA is a powerful tool for diagnosing esophageal strictures lacking typical malignant features. It reliably differentiates malignancy from challenging benign mimics, preventing misdiagnosis and guiding appropriate therapy. Clinicians should maintain a high suspicion for both occult malignancy and rare benign conditions in such stenotic lesions.
- Open Access
- 25 March 2025
- Published by MDPI AG in Preprints.org
Unexplained Urine Changes After EUS-HGS: A Rare Case Report
EUS-BD, including EUS-CDS and EUS-HGS, is an efficacious alternative to ERCP and its common complications are bile leak, infection, stent migration and bleeding. Here, we report an atypical case of a patient who developed dark green urine after receiving EUS-HGS, which we suspected to be caused by an abnormal biliary-vascular fistula. A 76-year-old woman diagnosed with pancreatic adenocarcinoma received EUS-HGS for relieving jaundice. The patient reported abdominal pain and chest tightness after the operation, with difficulty in urinating. X-ray suggested right-sided pleural effusion and dark green pleural effusion was drained out. However, the patient also developed dark green urine, which appeared everyday afternoon and disappeared automatically after intravenous treatment. The phenomenon was rare and interesting ,and also called for more alert on post-operative complication detection after EUS-BD operation.
- 25 March 2025
- Published by MDPI AG in Preprints.org
Open AccessUnexplained Urine Changes After EUS-HGS: A Rare Case Report
EUS-BD, including EUS-CDS and EUS-HGS, is an efficacious alternative to ERCP and its common complications are bile leak, infection, stent migration and bleeding. Here, we report an atypical case of a patient who developed dark green urine after receiving EUS-HGS, which we suspected to be caused by an abnormal biliary-vascular fistula. A 76-year-old woman diagnosed with pancreatic adenocarcinoma received EUS-HGS for relieving jaundice. The patient reported abdominal pain and chest tightness after the operation, with difficulty in urinating. X-ray suggested right-sided pleural effusion and dark green pleural effusion was drained out. However, the patient also developed dark green urine, which appeared everyday afternoon and disappeared automatically after intravenous treatment. The phenomenon was rare and interesting ,and also called for more alert on post-operative complication detection after EUS-BD operation.
- Open Access
- 1 September 2024
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 13 (5) , 293-299
The comparison of clinicopathological characteristics of two distinct manifestations of gastric signet ring cell carcinoma under EUS
Background and Objectives: There are two different endoscopic ultrasonographic manifestations of gastric signet ring cell carcinoma (GSRCC). No studies have been reported on the differences in the clinical profiles of patients based on EUS examination. We aim to study the variations in clinicopathological characteristics between two distinct endoscopic ultrasonographic manifestations of GSRCC. Methods: A total of 302 patients with GSRCC confirmed by pathological examination who underwent EUS were enrolled in the study. Based on the endoscopic ultrasonographic features, patients were categorized into two groups: type 1, where the entire layer structure disappeared, and type 2, where the layer structure was still present and appeared lymphomatoid. Clinicopathologic features were collected retrospectively and analyzed. Results: Compared with type 2 patients, type 1 patients tended to develop GSRCC at an older age (P = 0.033) and had higher serum levels of tumor markers and were more likely to experience anemia (P < 0.001) and weight loss (P < 0.001) during the disease progression. Significant increases in the tumor size (P < 0.001), thickness of the affected gastric wall (P < 0.001), and depth of tumor invasion (P < 0.001) were observed in type 1 patients. Furthermore, type 1 patients had higher prevalence of affected blood vessels (P < 0.001), nerves (P < 0.001), lymph nodes (P < 0.001), and peritoneal metastasis (P < 0.001). However, no difference was found in the duration of disease between the two groups, and all deficient mismatch repairs were observed in type 1 patients. Conclusions: The two distinct endoscopic ultrasonographic manifestations of GSRCC exhibited different clinicopathological characteristics, suggesting that they may represent different subtypes of the disease that require special attention in management strategies.
- 1 September 2024
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 13 (5) , 293-299
Open AccessThe comparison of clinicopathological characteristics of two distinct manifestations of gastric signet ring cell carcinoma under EUS
Background and Objectives: There are two different endoscopic ultrasonographic manifestations of gastric signet ring cell carcinoma (GSRCC). No studies have been reported on the differences in the clinical profiles of patients based on EUS examination. We aim to study the variations in clinicopathological characteristics between two distinct endoscopic ultrasonographic manifestations of GSRCC. Methods: A total of 302 patients with GSRCC confirmed by pathological examination who underwent EUS were enrolled in the study. Based on the endoscopic ultrasonographic features, patients were categorized into two groups: type 1, where the entire layer structure disappeared, and type 2, where the layer structure was still present and appeared lymphomatoid. Clinicopathologic features were collected retrospectively and analyzed. Results: Compared with type 2 patients, type 1 patients tended to develop GSRCC at an older age (P = 0.033) and had higher serum levels of tumor markers and were more likely to experience anemia (P < 0.001) and weight loss (P < 0.001) during the disease progression. Significant increases in the tumor size (P < 0.001), thickness of the affected gastric wall (P < 0.001), and depth of tumor invasion (P < 0.001) were observed in type 1 patients. Furthermore, type 1 patients had higher prevalence of affected blood vessels (P < 0.001), nerves (P < 0.001), lymph nodes (P < 0.001), and peritoneal metastasis (P < 0.001). However, no difference was found in the duration of disease between the two groups, and all deficient mismatch repairs were observed in type 1 patients. Conclusions: The two distinct endoscopic ultrasonographic manifestations of GSRCC exhibited different clinicopathological characteristics, suggesting that they may represent different subtypes of the disease that require special attention in management strategies.